Terms: = Lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
10144 results:
1. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract] [Full Text] [Related]
3. Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.
Hao Z; Fei Y; Chen J; Huang S; Wang L; Yu Y; Bian M; Si Y; Zhang X; Yang X; Zhang B; Wan Y; Zhang Y; Lin G
Hematology; 2024 Dec; 29(1):2344998. PubMed ID: 38666535
[TBL] [Abstract] [Full Text] [Related]
4. Infectious complications in pediatric patients undergoing CD19+CD22+ chimeric antigen receptor T-cell therapy for relapsed/refractory B-lymphoblastic leukemia.
Wu X; Cao Z; Chen Z; Wang Y; He H; Xiao P; Hu S; Lu J; Li B
Clin Exp Med; 2024 Apr; 24(1):87. PubMed ID: 38662121
[TBL] [Abstract] [Full Text] [Related]
5. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
6. Impact of the COVID-19 pandemic on utilization and cost for care of pediatric and young adult ALL.
Hoover A; Watson D; Reimche P; Tanner L; Gilchrist L; Finch M; Messinger YH; Turcotte LM
BMC Res Notes; 2024 Apr; 17(1):112. PubMed ID: 38644484
[TBL] [Abstract] [Full Text] [Related]
7. Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia: latest updates from the 2023 ASH annual meeting.
Shi T; Zhu HH
J Hematol Oncol; 2024 Apr; 17(1):18. PubMed ID: 38627786
[TBL] [Abstract] [Full Text] [Related]
8. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.
Lu Z; Lai Q; Li ZF; Zhong MY; Jiang YL; Feng LY; Zha J; Yao JW; Li Y; Deng XM; Xu B
Curr Med Sci; 2024 Apr; 44(2):298-308. PubMed ID: 38619682
[TBL] [Abstract] [Full Text] [Related]
9. Different Levels of Therapeutic Strategies to Recover the Microbiome to Prevent/Delay Acute Lymphoblastic Leukemia (ALL) or Arrest Its Progression in Children.
Aronica TS; Carella M; Balistreri CR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612738
[TBL] [Abstract] [Full Text] [Related]
10. A Rare Case of Methemoglobinemia after Ifosfamide Infusion in a 3-Year-Old Patient Treated for T-ALL.
Suprunowicz M; Marcinkiewicz K; Leszczyńska E; Krętowska-Grunwald A; Płonowski M; Tałałaj M; Dakowicz Ł; Krawczuk-Rybak M; Sawicka-Żukowska M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612599
[TBL] [Abstract] [Full Text] [Related]
11. Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.
Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
[TBL] [Abstract] [Full Text] [Related]
12. Update on FDG-PET in pediatric lymphoma.
Kurch L; Kluge R
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
[TBL] [Abstract] [Full Text] [Related]
13. A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens.
Xiong ZY; Shen YJ; Zhang SZ; Zhu HH
Hematology; 2024 Dec; 29(1):2335856. PubMed ID: 38581291
[TBL] [Abstract] [Full Text] [Related]
14. Involvement of bcr::ABL1 in laminin adhesion of Philadelphia chromosome-positive acute lymphoblastic leukemia through upregulation of integrin α6.
Takahashi K; Nguyen TTT; Watanabe A; Sato H; Saito K; Tamai M; Harama D; Kasai S; Akahane K; Goi K; Kagami K; Abe M; Komatsu C; Maeda Y; Sugita K; Inukai T
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2034. PubMed ID: 38577721
[TBL] [Abstract] [Full Text] [Related]
15. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
[TBL] [Abstract] [Full Text] [Related]
16. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
Liu Y; Zhang S; Tan Y
Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
[No Abstract] [Full Text] [Related]
17. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
18. The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
Enlund S; Sinha I; Neofytou C; Amor AR; Papadakis K; Nilsson A; Jiang Q; Hermanson O; Holm F
Exp Cell Res; 2024 Apr; 437(2):114015. PubMed ID: 38561062
[TBL] [Abstract] [Full Text] [Related]
19. Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling.
Mosquera Orgueira A; Krali O; Pérez Míguez C; Peleteiro Raíndo A; Díaz Arias JÁ; González Pérez MS; Pérez Encinas MM; Fernández Sanmartín M; Sinnet D; Heyman M; Lönnerholm G; Norén-Nyström U; Schmiegelow K; Nordlund J
Clin Epigenetics; 2024 Mar; 16(1):49. PubMed ID: 38549146
[TBL] [Abstract] [Full Text] [Related]
20. Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
Mouhssine S; Maher N; Matti BF; Alwan AF; Gaidano G
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542207
[TBL] [Abstract] [Full Text] [Related]
[Next]
